Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:290-296
Published online before print November 16, 2006, doi: 10.1161/01.ATV.0000252667.53790.4e
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
27/2/290    most recent
01.ATV.0000252667.53790.4ev1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, S. J.
Right arrow Articles by Smyth, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, S. J.
Right arrow Articles by Smyth, E. M.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:290.)
© 2007 American Heart Association, Inc.


Vascular Biology

Regulation of Thromboxane Receptor Trafficking Through the Prostacyclin Receptor in Vascular Smooth Muscle Cells

Role of Receptor Heterodimerization

Stephen J. Wilson; Jennifer K. Dowling; Lei Zhao; Erin Carnish; Emer M. Smyth

From the Institute of Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia.

Correspondence to Dr Emer M Smyth, Institute of Translational Medicine and Therapeutics, University of Pennsylvania, 808 BRB II/III, 421 Curie Blvd, Philadelphia, PA 19104. E-mail emer{at}spirit.gcrc.upenn.edu

Background— Prostacyclin (PGI2) and thromboxane (TxA2) effect disparate outcomes for atherogenesis and the response to vascular injury; PGI2, a vasodilator and inhibitor of platelet aggregation, limits the deleterious actions of TxA2, a vasoconstrictor and platelet activator. Dimerization of their G protein-coupled receptors, IP and TP, evokes a modified cellular response through which IP/TP counter-balance may be effected. We examined the consequence of IP/TP interaction for the regulatory pathways of both receptors.

Methods and Results— TP{alpha} overexpressed in HEK293 cells or expressed endogenously in aortic smooth muscle cells (ASMCs) was internalized after selective activation of either TP or IP. Homologous trafficking of TP was unaltered by coexpression of IP. Heterologous sequestration of TP{alpha} required the physical presence of activated IP, in transfected and native cells, but was independent of IP signaling to adenylyl cyclase. Reciprocal heterologous regulation of IP, via activated TP, was evident in both HEK293 cells and ASMCs. Homologous TP internalization led to receptor retention and degradation. In contrast, when internalization was IP-induced, TP{alpha} was recycled to the cell surface in coexpressing HEK293 cells, but not in ASMCs, in accord with the postendocytotic pathway of IP.

Conclusions— IP/TP{alpha} interaction permits reciprocal regulation of receptor endocytosis via the trafficking pathway determined by the activated dimeric partner.

Interaction of the G protein-coupled receptors for prostacyclin (IP) and thromboxane (TP) permits reciprocal regulation of receptor endocytosis via a trafficking pathway determined by the activated dimeric partner. This represents a further mechanism by which dimerization may effect the IP-TP counterbalance.


Key Words: prostacyclin • thromboxane • G protein-coupled receptor • heterodimer • internalization




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
S. J. Wilson, C. C. Cavanagh, A. M. Lesher, A. J. Frey, S. E. Russell, and E. M. Smyth
Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species
J. Lipid Res., June 1, 2009; 50(6): 1047 - 1056.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Damian, S. Mary, A. Martin, J.-P. Pin, and J.-L. Baneres
G Protein Activation by the Leukotriene B4 Receptor Dimer: EVIDENCE FOR AN ABSENCE OF TRANS-ACTIVATION
J. Biol. Chem., July 25, 2008; 283(30): 21084 - 21092.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. M. Sellers and J. N. Stallone
Sympathy for the devil: the role of thromboxane in the regulation of vascular tone and blood pressure
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H1978 - H1986.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Subbaramaiah, C. Hudis, S.-H. Chang, T. Hla, and A. J. Dannenberg
EP2 and EP4 Receptors Regulate Aromatase Expression in Human Adipocytes and Breast Cancer Cells: EVIDENCE OF A BRCA1 AND p300 EXCHANGE
J. Biol. Chem., February 8, 2008; 283(6): 3433 - 3444.
[Abstract] [Full Text] [PDF]